« Back
Home /
Labetuzumab govitecan

Labetuzumab govitecan

Item no.	TMO-T25593-5mg
Manufacturer	TargetMol
CASRN	1469876-18-3
Amount	5 mg
Quantity options	100 mg 1 mg 500 mg 5 mg
Category	Reagents & Chemicals Biochemicals
Type	Chemicals
Specific against	other
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Alias	IMMU-130,Labetuzumab-SN38,hMN14-SN38,IMMU130,IMMU 130
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Antibody-Drug Conjugates (ADCs)
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	566, 62
Description	Labetuzumab govitecan is an anti-CEACAM5/SN-38 antibody-drug conjugate for therapy of refractory or relapsing metastatic colorectal cancer.
Pathways	Antibody-drug Conjugate/ADC Related

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T25593-5mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question